Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 197 entries
Sorted by: Best Match Show Resources per page
Thermoluminescence behavior of basaltic rocks collected in southeastern region of Turkey.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine

Toktamış D, Toktamış H, Yazıcı AN.
PMID: 28049067
Appl Radiat Isot. 2017 Mar;121:109-115. doi: 10.1016/j.apradiso.2016.12.051. Epub 2016 Dec 29.

Basalt is well known as an extrusive igneous rock erupts on land by volcanic eruption. It is darker, denser and finer grained compared to the familiar granite of the continents. The study reveals the thermoluminescence properties (TL) of basaltic...

Cite
Toktamış D, Toktamış H, Yazıcı AN. Thermoluminescence behavior of basaltic rocks collected in southeastern region of Turkey. Appl Radiat Isot. 2016;121:109-115doi: 10.1016/j.apradiso.2016.12.051.
Toktamış, D., Toktamış, H., & Yazıcı, A. N. (2017). Thermoluminescence behavior of basaltic rocks collected in southeastern region of Turkey. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 121109-115. https://doi.org/10.1016/j.apradiso.2016.12.051
Toktamış, Dilek, et al. "Thermoluminescence behavior of basaltic rocks collected in southeastern region of Turkey." Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine vol. 121 (2017): 109-115. doi: https://doi.org/10.1016/j.apradiso.2016.12.051
Toktamış D, Toktamış H, Yazıcı AN. Thermoluminescence behavior of basaltic rocks collected in southeastern region of Turkey. Appl Radiat Isot. 2017 Mar;121:109-115. doi: 10.1016/j.apradiso.2016.12.051. Epub 2016 Dec 29. PMID: 28049067.
Copy Download .nbib Format: NLM
An unusual stress fracture in an archer with hypophosphatasia.

Case reports in orthopedics

Yavuz U, Sökücü S, Demir B, Akpınar E, Lapçin O, Atıcı Y, Kabukçuoğlu Y.
PMID: 24383027
Case Rep Orthop. 2013;2013:350236. doi: 10.1155/2013/350236. Epub 2013 Dec 09.

We report a 45-year-old male archer with stress fracture in his left ulna on the background of adult type of hypophosphatasia. The patient presented to several medical centers for pain around the left elbow and received medical treatment upon...

Cite
Yavuz U, Sökücü S, Demir B, et al. An unusual stress fracture in an archer with hypophosphatasia. Case Rep Orthop. 2013;2013:350236doi: 10.1155/2013/350236.
Yavuz, U., Sökücü, S., Demir, B., Akpınar, E., Lapçin, O., Atıcı, Y., & Kabukçuoğlu, Y. (2013). An unusual stress fracture in an archer with hypophosphatasia. Case reports in orthopedics, 2013350236. https://doi.org/10.1155/2013/350236
Yavuz, Umut, et al. "An unusual stress fracture in an archer with hypophosphatasia." Case reports in orthopedics vol. 2013 (2013): 350236. doi: https://doi.org/10.1155/2013/350236
Yavuz U, Sökücü S, Demir B, Akpınar E, Lapçin O, Atıcı Y, Kabukçuoğlu Y. An unusual stress fracture in an archer with hypophosphatasia. Case Rep Orthop. 2013;2013:350236. doi: 10.1155/2013/350236. Epub 2013 Dec 09. PMID: 24383027; PMCID: PMC3872236.
Copy Download .nbib Format: NLM
(E)-2-Hydr-oxy-6-[(4-propyl-phenyl)-iminiometh-yl]phenolate.

Acta crystallographica. Section E, Structure reports online

Yazıcı S, Albayrak C, Gümrükçüoğlu I, Senel I, Büyükgüngör O.
PMID: 21580188
Acta Crystallogr Sect E Struct Rep Online. 2009 Dec 09;66:o93. doi: 10.1107/S1600536809052246.

The title compound, C(16)H(17)NO(2), crystallizes with three crystallographically independent zwitterionic mol-ecules in the asymmetric unit which differ significantly in the orientations of the propyl side chains. The dihedral angles between the two benzene rings in the three mol-ecules are...

Cite
Yazıcı S, Albayrak C, Gümrükçüoğlu I, et al. (E)-2-Hydr-oxy-6-[(4-propyl-phenyl)-iminiometh-yl]phenolate. Acta Crystallogr Sect E Struct Rep Online. 2009;66:o93doi: 10.1107/S1600536809052246.
Yazıcı, S., Albayrak, C., Gümrükçüoğlu, I., Senel, I., & Büyükgüngör, O. (2009). (E)-2-Hydr-oxy-6-[(4-propyl-phenyl)-iminiometh-yl]phenolate. Acta crystallographica. Section E, Structure reports online, 66o93. https://doi.org/10.1107/S1600536809052246
Yazıcı, Serap, et al. "(E)-2-Hydr-oxy-6-[(4-propyl-phenyl)-iminiometh-yl]phenolate." Acta crystallographica. Section E, Structure reports online vol. 66 (2009): o93. doi: https://doi.org/10.1107/S1600536809052246
Yazıcı S, Albayrak C, Gümrükçüoğlu I, Senel I, Büyükgüngör O. (E)-2-Hydr-oxy-6-[(4-propyl-phenyl)-iminiometh-yl]phenolate. Acta Crystallogr Sect E Struct Rep Online. 2009 Dec 09;66:o93. doi: 10.1107/S1600536809052246. PMID: 21580188; PMCID: PMC2980080.
Copy Download .nbib Format: NLM
(E)-2-[(2-Ethyl-phen-yl)imino-meth-yl]-6-methoxy-phenol.

Acta crystallographica. Section E, Structure reports online

Yazıcı S, Albayrak C, Gümrükçüoğlu I, Senel I, Büyükgüngör O.
PMID: 21579722
Acta Crystallogr Sect E Struct Rep Online. 2010 Jan 09;66:o287. doi: 10.1107/S1600536809055573.

The mol-ecule of the title compound, C(16)H(17)NO(2), adopts the phenol-imine tautomeric form with a strong intra-molecular O-H⋯N hydrogen bond and an E conformation with respect to the azomethine C=N bond. The dihedral angle between the aromatic rings is 21.23...

Cite
Yazıcı S, Albayrak C, Gümrükçüoğlu I, et al. (E)-2-[(2-Ethyl-phen-yl)imino-meth-yl]-6-methoxy-phenol. Acta Crystallogr Sect E Struct Rep Online. 2010;66:o287doi: 10.1107/S1600536809055573.
Yazıcı, S., Albayrak, C., Gümrükçüoğlu, I., Senel, I., & Büyükgüngör, O. (2010). (E)-2-[(2-Ethyl-phen-yl)imino-meth-yl]-6-methoxy-phenol. Acta crystallographica. Section E, Structure reports online, 66o287. https://doi.org/10.1107/S1600536809055573
Yazıcı, Serap, et al. "(E)-2-[(2-Ethyl-phen-yl)imino-meth-yl]-6-methoxy-phenol." Acta crystallographica. Section E, Structure reports online vol. 66 (2010): o287. doi: https://doi.org/10.1107/S1600536809055573
Yazıcı S, Albayrak C, Gümrükçüoğlu I, Senel I, Büyükgüngör O. (E)-2-[(2-Ethyl-phen-yl)imino-meth-yl]-6-methoxy-phenol. Acta Crystallogr Sect E Struct Rep Online. 2010 Jan 09;66:o287. doi: 10.1107/S1600536809055573. PMID: 21579722; PMCID: PMC2979675.
Copy Download .nbib Format: NLM
1-{5-[(E)-(2-Fluoro-phen-yl)diazen-yl]-2-hy-droxy-phen-yl}ethanone.

Acta crystallographica. Section E, Structure reports online

Yazıcı S, Albayrak C, Gümrükçüoğlu I, Senel I, Büyükgüngör O.
PMID: 21522392
Acta Crystallogr Sect E Struct Rep Online. 2011 Feb 16;67:o639. doi: 10.1107/S1600536811004909.

Theere are two independent mol-ecules in the asymmetric unit of the title compound, C(14)H(11)FN(2)O(2), each with a trans configuration with respect to the azo double bond. The dihedral angle between the aromatic rings is 17.21 (2)° in one mol-ecule...

Cite
Yazıcı S, Albayrak C, Gümrükçüoğlu I, et al. 1-{5-[(E)-(2-Fluoro-phen-yl)diazen-yl]-2-hy-droxy-phen-yl}ethanone. Acta Crystallogr Sect E Struct Rep Online. 2011;67:o639doi: 10.1107/S1600536811004909.
Yazıcı, S., Albayrak, C., Gümrükçüoğlu, I., Senel, I., & Büyükgüngör, O. (2011). 1-{5-[(E)-(2-Fluoro-phen-yl)diazen-yl]-2-hy-droxy-phen-yl}ethanone. Acta crystallographica. Section E, Structure reports online, 67o639. https://doi.org/10.1107/S1600536811004909
Yazıcı, Serap, et al. "1-{5-[(E)-(2-Fluoro-phen-yl)diazen-yl]-2-hy-droxy-phen-yl}ethanone." Acta crystallographica. Section E, Structure reports online vol. 67 (2011): o639. doi: https://doi.org/10.1107/S1600536811004909
Yazıcı S, Albayrak C, Gümrükçüoğlu I, Senel I, Büyükgüngör O. 1-{5-[(E)-(2-Fluoro-phen-yl)diazen-yl]-2-hy-droxy-phen-yl}ethanone. Acta Crystallogr Sect E Struct Rep Online. 2011 Feb 16;67:o639. doi: 10.1107/S1600536811004909. PMID: 21522392; PMCID: PMC3051973.
Copy Download .nbib Format: NLM
1-{5-[(E)-(4-Propyl-phen-yl)diazen-yl]-2-hy-droxy-phen-yl}ethanone.

Acta crystallographica. Section E, Structure reports online

Yazıcı S, Albayrak C, Gümrükçüoğlu I, Senel I, Büyükgüngör O.
PMID: 21522393
Acta Crystallogr Sect E Struct Rep Online. 2011 Feb 16;67:o640. doi: 10.1107/S1600536811004910.

The mol-ecular geometry of the title compound, C(17)H(18)N(2)O(2), displays an E configuration with respect to the azo group. The dihedral angle between the aromatic rings is 10.39 (4)°. In the mol-ecule, an intra-molecular O-H⋯O hydrogen bond generates an S(6)...

Cite
Yazıcı S, Albayrak C, Gümrükçüoğlu I, et al. 1-{5-[(E)-(4-Propyl-phen-yl)diazen-yl]-2-hy-droxy-phen-yl}ethanone. Acta Crystallogr Sect E Struct Rep Online. 2011;67:o640doi: 10.1107/S1600536811004910.
Yazıcı, S., Albayrak, C., Gümrükçüoğlu, I., Senel, I., & Büyükgüngör, O. (2011). 1-{5-[(E)-(4-Propyl-phen-yl)diazen-yl]-2-hy-droxy-phen-yl}ethanone. Acta crystallographica. Section E, Structure reports online, 67o640. https://doi.org/10.1107/S1600536811004910
Yazıcı, Serap, et al. "1-{5-[(E)-(4-Propyl-phen-yl)diazen-yl]-2-hy-droxy-phen-yl}ethanone." Acta crystallographica. Section E, Structure reports online vol. 67 (2011): o640. doi: https://doi.org/10.1107/S1600536811004910
Yazıcı S, Albayrak C, Gümrükçüoğlu I, Senel I, Büyükgüngör O. 1-{5-[(E)-(4-Propyl-phen-yl)diazen-yl]-2-hy-droxy-phen-yl}ethanone. Acta Crystallogr Sect E Struct Rep Online. 2011 Feb 16;67:o640. doi: 10.1107/S1600536811004910. PMID: 21522393; PMCID: PMC3052044.
Copy Download .nbib Format: NLM
Treatment options for rheumatoid arthritis beyond TNF-α inhibitors.

Expert review of clinical pharmacology

Yazici Y, Simsek I.
PMID: 22111748
Expert Rev Clin Pharmacol. 2010 Sep;3(5):663-6. doi: 10.1586/ecp.10.47.

The treatment of rheumatoid arthritis has changed over the last 15 years. Early and aggressive treatment, use of methotrexate as the anchor drug and combination treatment, with older disease-modifying drugs or biologics, have become the norm. TNF inhibitors were...

Cite
Yazici Y, Simsek I. Treatment options for rheumatoid arthritis beyond TNF-α inhibitors. Expert Rev Clin Pharmacol. 2010;3(5):663-6doi: 10.1586/ecp.10.47.
Yazici, Y., & Simsek, I. (2010). Treatment options for rheumatoid arthritis beyond TNF-α inhibitors. Expert review of clinical pharmacology, 3(5), 663-6. https://doi.org/10.1586/ecp.10.47
Yazici, Yusuf, and Simsek, Ismail. "Treatment options for rheumatoid arthritis beyond TNF-α inhibitors." Expert review of clinical pharmacology vol. 3,5 (2010): 663-6. doi: https://doi.org/10.1586/ecp.10.47
Yazici Y, Simsek I. Treatment options for rheumatoid arthritis beyond TNF-α inhibitors. Expert Rev Clin Pharmacol. 2010 Sep;3(5):663-6. doi: 10.1586/ecp.10.47. PMID: 22111748.
Copy Download .nbib Format: NLM
The coexistence of multiple sclerosis and hereditary spastic paraparesis in a patient.

Neurology international

Yazıcı I, Yıldırım N, Zorlu Y.
PMID: 23888209
Neurol Int. 2013 Jun 25;5(2):17-9. doi: 10.4081/ni.2013.e6. Print 2013 Jun 25.

Multiple sclerosis (MS) is a chronic disease characterized by multiple areas of central nervous system inflammation, demyelination and axonal loss. Hereditary spastic paraparesis (HSP) is characterized clinically by progressive spasticity and weakness of the lower limbs and pathologically by...

Cite
Yazıcı I, Yıldırım N, Zorlu Y. The coexistence of multiple sclerosis and hereditary spastic paraparesis in a patient. Neurol Int. 2013;5(2):17-9doi: 10.4081/ni.2013.e6.
Yazıcı, I., Yıldırım, N., & Zorlu, Y. (2013). The coexistence of multiple sclerosis and hereditary spastic paraparesis in a patient. Neurology international, 5(2), 17-9. https://doi.org/10.4081/ni.2013.e6
Yazıcı, Işıl, et al. "The coexistence of multiple sclerosis and hereditary spastic paraparesis in a patient." Neurology international vol. 5,2 (2013): 17-9. doi: https://doi.org/10.4081/ni.2013.e6
Yazıcı I, Yıldırım N, Zorlu Y. The coexistence of multiple sclerosis and hereditary spastic paraparesis in a patient. Neurol Int. 2013 Jun 25;5(2):17-9. doi: 10.4081/ni.2013.e6. Print 2013 Jun 25. PMID: 23888209; PMCID: PMC3718246.
Copy Download .nbib Format: NLM
[No title available]

Molecular imaging and radionuclide therapy

Oral A, Yazıcı B, Ömür Ö.
PMID: 30317852
Mol Imaging Radionucl Ther. 2018 Oct 09;27(3):138-140. doi: 10.4274/mirt.63497.

A sixty-two-year-old male patient underwent orchiectomy and was diagnosed with diffuse large B-cell lymphoma in the testicle and spermatic cord.

Cite
Oral A, Yazıcı B, Ömür Ö. . Mol Imaging Radionucl Ther. 2018;27(3):138-140doi: 10.4274/mirt.63497.
Oral, A., Yazıcı, B., & Ömür, �. �. (2018). . Molecular imaging and radionuclide therapy, 27(3), 138-140. https://doi.org/10.4274/mirt.63497
Oral, Aylin, et al. "." Molecular imaging and radionuclide therapy vol. 27,3 (2018): 138-140. doi: https://doi.org/10.4274/mirt.63497
Oral A, Yazıcı B, Ömür Ö. . Mol Imaging Radionucl Ther. 2018 Oct 09;27(3):138-140. doi: 10.4274/mirt.63497. PMID: 30317852; PMCID: PMC6191729.
Copy Download .nbib Format: NLM
Unexpected False-positive I-131 Uptake in Patients with Differentiated Thyroid Carcinoma.

Molecular imaging and radionuclide therapy

Oral A, Yazıcı B, Eraslan C, Burak Z.
PMID: 30317832
Mol Imaging Radionucl Ther. 2018 Oct 09;27(3):99-106. doi: 10.4274/mirt.37450.

OBJECTIVE: Radioiodine is the most specific radionuclide for differentiated thyroid carcinoma (DTC) imaging. Despite its high specificity and sensitivity, false-positive I-131 uptake could be seen on whole body scan (WBS) that may lead to misdiagnosis and unnecessary radioiodine treatment....

Cite
Oral A, Yazıcı B, Eraslan C, et al. Unexpected False-positive I-131 Uptake in Patients with Differentiated Thyroid Carcinoma. Mol Imaging Radionucl Ther. 2018;27(3):99-106doi: 10.4274/mirt.37450.
Oral, A., Yazıcı, B., Eraslan, C., & Burak, Z. (2018). Unexpected False-positive I-131 Uptake in Patients with Differentiated Thyroid Carcinoma. Molecular imaging and radionuclide therapy, 27(3), 99-106. https://doi.org/10.4274/mirt.37450
Oral, Aylin, et al. "Unexpected False-positive I-131 Uptake in Patients with Differentiated Thyroid Carcinoma." Molecular imaging and radionuclide therapy vol. 27,3 (2018): 99-106. doi: https://doi.org/10.4274/mirt.37450
Oral A, Yazıcı B, Eraslan C, Burak Z. Unexpected False-positive I-131 Uptake in Patients with Differentiated Thyroid Carcinoma. Mol Imaging Radionucl Ther. 2018 Oct 09;27(3):99-106. doi: 10.4274/mirt.37450. PMID: 30317832; PMCID: PMC6191736.
Copy Download .nbib Format: NLM
A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer.

Asian Pacific journal of cancer prevention : APJCP

Bozkaya Y, Özdemir NY, Yazıcı O, Demirci NS, Kurtipek A, Erdem GU, Ergün Y, Zengin N.
PMID: 29374414
Asian Pac J Cancer Prev. 2018 Jan 27;19(1):283-290. doi: 10.22034/APJCP.2018.19.1.283.

Objective: We aimed to evaluate the effectiveness of an mEOX (modified epirubicin, oxaliplatin plus capecitabine) regimen as second line therapy after failure of mDCF (modified docetaxel, cisplatin plus fluorouracil). Methods: Gastic cancer patients for whom first-line therapy was unsuccessful...

Cite
Bozkaya Y, Özdemir NY, Yazıcı O, et al. A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer. Asian Pac J Cancer Prev. 2018;19(1):283-290doi: 10.22034/APJCP.2018.19.1.283.
Bozkaya, Y., Özdemir, N. Y., Yazıcı, O., Demirci, N. S., Kurtipek, A., Erdem, G. U., Ergün, Y., & Zengin, N. (2018). A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer. Asian Pacific journal of cancer prevention : APJCP, 19(1), 283-290. https://doi.org/10.22034/APJCP.2018.19.1.283
Bozkaya, Yakup, et al. "A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer." Asian Pacific journal of cancer prevention : APJCP vol. 19,1 (2018): 283-290. doi: https://doi.org/10.22034/APJCP.2018.19.1.283
Bozkaya Y, Özdemir NY, Yazıcı O, Demirci NS, Kurtipek A, Erdem GU, Ergün Y, Zengin N. A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer. Asian Pac J Cancer Prev. 2018 Jan 27;19(1):283-290. doi: 10.22034/APJCP.2018.19.1.283. PMID: 29374414; PMCID: PMC5844632.
Copy Download .nbib Format: NLM
Comparison of the Effects of Magnetically Controlled Growing Rod and Tradiotinal Growing Rod Techniques on the Sagittal Plane in the Treatment of Early-Onset Scoliosis.

Journal of Korean Neurosurgical Society

Erdoğan S, Polat B, Atıcı Y, Özyalvaç ON, Öztürk Ç.
PMID: 31484232
J Korean Neurosurg Soc. 2019 Sep;62(5):577-585. doi: 10.3340/jkns.2019.0094. Epub 2019 Aug 30.

OBJECTIVE: Comparing the effects of magnetically controlled growing rod (MCGR) and traditional growing rod (TGR) techniques on the sagittal plane in the treatment of early-onset scoliosis (EOS).METHODS: Twelve patients were operated using dual MCGR technique in one center, while...

Cite
Erdoğan S, Polat B, Atıcı Y, et al. Comparison of the Effects of Magnetically Controlled Growing Rod and Tradiotinal Growing Rod Techniques on the Sagittal Plane in the Treatment of Early-Onset Scoliosis. J Korean Neurosurg Soc. 2019;62(5):577-585doi: 10.3340/jkns.2019.0094.
Erdoğan, S., Polat, B., Atıcı, Y., Özyalvaç, O. N., & Öztürk, �. �. (2019). Comparison of the Effects of Magnetically Controlled Growing Rod and Tradiotinal Growing Rod Techniques on the Sagittal Plane in the Treatment of Early-Onset Scoliosis. Journal of Korean Neurosurgical Society, 62(5), 577-585. https://doi.org/10.3340/jkns.2019.0094
Erdoğan, Sinan, et al. "Comparison of the Effects of Magnetically Controlled Growing Rod and Tradiotinal Growing Rod Techniques on the Sagittal Plane in the Treatment of Early-Onset Scoliosis." Journal of Korean Neurosurgical Society vol. 62,5 (2019): 577-585. doi: https://doi.org/10.3340/jkns.2019.0094
Erdoğan S, Polat B, Atıcı Y, Özyalvaç ON, Öztürk Ç. Comparison of the Effects of Magnetically Controlled Growing Rod and Tradiotinal Growing Rod Techniques on the Sagittal Plane in the Treatment of Early-Onset Scoliosis. J Korean Neurosurg Soc. 2019 Sep;62(5):577-585. doi: 10.3340/jkns.2019.0094. Epub 2019 Aug 30. PMID: 31484232; PMCID: PMC6732347.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 197 entries